AI-powered cardiac MRI solution gains FDA clearance

Michael Walter | | Health Exec | Economics
""

HeartVista, a Los Altos, California-based healthcare technology company, has received FDA clearance for its AI-powered One Click cardiac MRI solution.

According to HeartVista, One Click removes many of the limitations of cardiac MRI and makes it “simple, time-efficient, affordable and highly consistent.”

“Patients across the country now have access to the only AI-guided cardiac MRI exam, which will deliver continuous imaging via an automated process, minimize errors and simplify scan operation,” Itamar Kandel, CEO of HeartVista, said in a prepared statement. “Our AI solution generates definitive, accurate and actionable real-time data for cardiologists. We believe it will elevate the standard of care for cardiac imaging, enhance patient experience and access and improve patient outcomes.”

Kandel also highlighted a study published by the New England Journal of Medicine in June 2019, noting that cardiac MRI was found to be “the gold standard for cardiac diagnosis, even when compared against invasive alternatives.”

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

Q&A: Vulnerable patients hit hardest by anesthesia reimbursement cuts
Momentum continues for renal denervation as CMS considers national Medicare coverage
Johnson & Johnson buys depression drug and its manufacturer for $15B
UnitedHealth, Amedisys ask federal judge to dismiss DOJ lawsuit blocking $3.3B merger
UnitedHealth shareholders push company to report on impact of claims denials
Reimbursement update: What hospitals need to know about new Medicare payments for cardiac CT

Around the web

AI in Healthcare
4 ways HHS plans to help shape a national strategy for healthcare AI

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.

Cardiovascular Business
FDA announces recall after Philips heart monitor software failed to send alerts—multiple deaths reported

Philips is recalling the software associated with its Mobile Cardiac Outpatient Telemetry devices after certain high-risk ECG events were never routed to trained cardiology technicians as intended. The issue, which lasted for two years, has been linked to more than 100 injuries. 

Cardiovascular Business
Why electrophysiologists needed a champion in Washington

Heart Rhythm Society President Kenneth A. Ellenbogen, MD, detailed a new advocacy group focused on improving EP reimbursements, patient care and access. “If you’re not at the table, you’re on the menu," he said.